胸腔镜、开胸手术治疗早期非小细胞肺癌临床对比研究  

The Clinical Comparative Study on the Treatment of Non Small Cell Lung Cancer in Patients with Early Stage Non Small Cell Lung Cancer

作　　者：谷凡 

机构地区：[1]河南省鹤壁市鹤煤总医院心胸外科,河南鹤壁458000

出　　处：《中外医疗》2016年第22期46-47,54,共3页China & Foreign Medical Treatment

摘　　要：目的探究在治疗早期非小细胞肺癌分别采用胸腔镜和开胸手术的临床效果。方法方便选取2013年6月—2015年6月该院治疗的早期非小细胞肺癌病人110例,随机分成探究组和参照组,探究组采取胸腔镜治疗,参照组进行开胸手术治疗,对比两组患者失血量、院内治疗时长、免疫力、并发症等情况。结果探究组治疗中失血量平均为(163.13±7.53)m L,在院内接受治疗时长平均为(7.34±1.37)d,治疗后的探究组免疫指标如Ig G水平为(12.03±2.17)g/L,同时探究组产生不适症状的人数(6例),以上数据相比于参照组,差异有统计学意义(P<0.05)。结论对于临床的早期非小细胞肺癌病人采用胸腔镜进行治疗在不影响机体免疫力的情况下,促进病情的恢复,减少不适症状的发生,推荐临床广泛应用。Objective To explore in the early treatment of non small cell lung cancer respectively by thoracoscopic and open chest surgery clinical effect. Methods Convenient selection June 2013 to June 2015 treated in our hospital in the early non small cell lung cancer patients in 110 cases, were randomly divided into study group and the reference group, research group take thoracoscopy in the treatment and reference group for thoracic surgery, Compared with the two groups of patients with blood loss, hospital treatment for a long time, immunity, complications, and so on. Results Into treatment group in blood loss averaged（163.13±7.53） mL of, in the hospital treated long average（7.34±1.37） d, after treatment of the study group immune indexes such as the level of IgG（12.03±2.17） g/L, and explore the group produce symptoms of number（6 cases）, the above data compared to the reference group were different, the difference has statistical value（P〈0.05）.Conclusion For clinical early stage non small cell lung cancer patients by thoracoscopic treatment in does not affect the machine body immunity, promote patient recovery, reduce incidence of symptoms, recommended in clinical application.

关 键 词：治疗效果 早期非小细胞肺癌 胸腔镜治疗 开胸手术 

分 类 号：R5[医药卫生—内科学]